Investor Presentaiton
600
JAPFA
PT Japfa Tbk: Vaksindo 4-year trend
Revenue
IDR Billion
Operating Profit
IDR Billion
→
250
499
490
500
399
408
200
372
400
300
200
100
141
144
150
100
133
129
137
50
196
188
149
54
53
42
0
0
FY2019 FY2020
FY2021 FY2022 1Q2023 2Q2023 3Q2023
FY2019 FY2020 FY2021 FY2022 1Q2023 2Q2023 3Q2023
Vaksindo continues to deliver steady growth and profitability
.
• Established in 1983, producing a range of livestock vaccines primarily for poultry
•
•
Japfa is the only poultry producer in Indonesia with its own in-house vaccine research and production
facility provides a strategic defense against one of the key risks in livestock production
Vaksindo has the expertise to produce Avian Influenza H5N1 vaccines since 2004 and is now one of the
leading producers providing vaccines of matching strains
-
Research based constant disease monitoring leading to new discoveries and continuously updated
vaccines. Vaksindo is Indonesia's leading animal health company that pioneered domestic research of
endemic respiratory diseases in poultry.
Leader in the Indonesian market and presently exporting to 14 countries
•
Vaksindo owns and operates two production plants in Bogor, Indonesia. Vaksindo has expanded overseas
with a presence in India and more recently Vietnam
21View entire presentation